Harbor Investment Advisory’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $84.2K | Buy |
555
+164
| +42% | +$24.9K | 0.01% | 528 |
|
|
2025
Q1 | $58.9K | Sell |
391
-195
| -33% | -$29.4K | 0.01% | 569 |
|
|
2024
Q4 | $108K | Buy |
586
+15
| +3% | +$2.77K | 0.01% | 440 |
|
|
2024
Q3 | $112K | Sell |
571
-351
| -38% | -$69.1K | 0.01% | 436 |
|
|
2024
Q2 | $190K | Buy |
922
+328
| +55% | +$67.8K | 0.02% | 339 |
|
|
2024
Q1 | $161K | Sell |
594
-350
| -37% | -$94.8K | 0.02% | 373 |
|
|
2023
Q4 | $223K | Buy |
944
+80
| +9% | +$18.9K | 0.03% | 309 |
|
|
2023
Q3 | $169K | Buy |
864
+530
| +159% | +$104K | 0.02% | 328 |
|
|
2023
Q2 | $70.2K | Buy |
334
+234
| +234% | +$49.2K | 0.01% | 607 |
|
|
2023
Q1 | $20.2K | Hold |
100
| – | – | ﹤0.01% | 911 |
|
|
2022
Q4 | $21.8K | Hold |
100
| – | – | ﹤0.01% | 887 |
|
|
2022
Q3 | $20K | Hold |
100
| – | – | ﹤0.01% | 907 |
|
|
2022
Q2 | $21K | Hold |
100
| – | – | ﹤0.01% | 892 |
|
|
2022
Q1 | $28K | Hold |
100
| – | – | ﹤0.01% | 875 |
|
|
2021
Q4 | $38K | Hold |
100
| – | – | ﹤0.01% | 815 |
|
|
2021
Q3 | $41K | Hold |
100
| – | – | 0.01% | 784 |
|
|
2021
Q2 | $37K | Hold |
100
| – | – | 0.01% | 778 |
|
|
2021
Q1 | $29K | Buy |
+100
| New | +$29K | ﹤0.01% | 800 |
|